148 related articles for article (PubMed ID: 2016229)
1. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):246-56. PubMed ID: 2016229
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
3. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.
Aman MG; Kern RA; McGhee DE; Arnold LE
J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):851-9. PubMed ID: 8340309
[TBL] [Abstract][Full Text] [Related]
4. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
Varley CK; Trupin EW
Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
[TBL] [Abstract][Full Text] [Related]
5. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.
Barkley RA; DuPaul GJ; McMurray MB
Pediatrics; 1991 Apr; 87(4):519-31. PubMed ID: 2011430
[TBL] [Abstract][Full Text] [Related]
6. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.
Aman MG; Kern RA; Osborne P; Tumuluru R; Rojahn J; del Medico V
Am J Ment Retard; 1997 Mar; 101(5):521-34. PubMed ID: 9083608
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.
Handen BL; Feldman HM; Lurier A; Murray PJ
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):805-12. PubMed ID: 10405497
[TBL] [Abstract][Full Text] [Related]
9. Does methylphenidate normalize the classroom performance of children with attention deficit disorder?
DuPaul GJ; Rapport MD
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):190-8. PubMed ID: 8428871
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.
Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):816-24. PubMed ID: 1938800
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
Brown RT; Wynne ME; Slimmer LW
J Clin Psychiatry; 1984 Nov; 45(11):473-6. PubMed ID: 6386794
[TBL] [Abstract][Full Text] [Related]
12. Effects and noneffects of methylphenidate in children with mental retardation and ADHD.
Handen BL; Breaux AM; Janosky J; McAuliffe S; Feldman H; Gosling A
J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):455-61. PubMed ID: 1592777
[TBL] [Abstract][Full Text] [Related]
13. Adverse side effects of methylphenidate among mentally retarded children with ADHD.
Handen BL; Feldman H; Gosling A; Breaux AM; McAuliffe S
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):241-5. PubMed ID: 2016228
[TBL] [Abstract][Full Text] [Related]
14. Prediction of response to methylphenidate among children with ADHD and mental retardation.
Handen BL; Janosky J; McAuliffe S; Breaux AM; Feldman H
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1185-93. PubMed ID: 7982869
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder.
Klorman R; Brumaghim JT; Fitzpatrick PA; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):702-9. PubMed ID: 2228922
[TBL] [Abstract][Full Text] [Related]
20. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
Akhondzadeh S; Tavakolian R; Davari-Ashtiani R; Arabgol F; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
